ARTICLE | Company News
Favrille, Bayer deal
February 19, 2007 8:00 AM UTC
BAY’s Berlex Laboratories Inc. subsidiary and FVRL partnered to use FVRL’s FavId in combination with Berlex’s Leukine sargramostim to treat B cell non-Hodgkin’s lymphoma (NHL). Each company received...